SCHEMBL29800705

SCHEMBL29800705

Cc1ccc2c(c1)Oc1cc(C=O)ccc1C(=O)N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.47
POLB P06746 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
TP53 P04637 2/20 0.47
ALDH1A1 P00352 4/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MITF O75030 1/20 0.46
HTT P42858 1/20 0.46
LMNA P02545 2/20 0.45
ROS1 P08922 1/20 0.42
CDK5 Q00535 1/20 0.42
ACVR1 Q04771 1/20 0.42
LRRK2 Q5S007 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CSNK1G1 Q9HCP0 1/20 0.40
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23269277 1.00 MAPT (0.47) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23269246 1.00 MAPT (0.47) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23242549 0.89 MAPT (0.56) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23242512 0.88 MAPT (0.46) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL29800621 0.88 MAPT (0.46) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23242583 0.88 MAPT (0.46) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23242498 0.81 MAPT (0.49) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23242548 0.81 CES1 (0.51) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23242600 0.81 MAPT (0.49) MAPTPOLBTDP1TP53ALDH1A1
SCHEMBL23242613 0.81 MAPT (0.49) MAPTPOLBTDP1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114929688-B 3- (4- (11H-dibenzo [ b, e ] [1,4] azepin-6-yl) piperazin-1-yl) -and 3- (4- (dibenzo [ b, f ] [1,4] oxazepin/thiazepin/diazepin-11-yl) piperazin-1-yl) -propionic acid derivatives as H1 and 5-HT 2A-receptor modulators for the treatment of sleep disorders 阿莱瑞恩公司 2024-11-01 CN disclosed
EP-4048667-B1 3-(4-(11H-DIBENZO[B,E][1,4]AZEPIN-6-YL)PIPERAZIN-1-YL)- AND 3-(4-(DIBENZO[B,F][1,4]OXAZEPIN/THIAZEPIN/DIAZEPIN-11-YL)PIPERAZIN-1-YL)-PROPANOIC ACID DERIVATIVES AS H1 AND 5-HT2A-RECEPTOR MODULATORS FOR THE TREATMENT OF SLEEP DISORDERS ALAIRION INC (US) 2024-07-03 EP disclosed
EP-4048667-A1 3-(4-(11H-DIBENZO[B,E][1,4]AZEPIN-6-YL)PIPERAZIN-1-YL)- AND 3-(4-(DIBENZO[B,F][1,4]OXAZEPIN/THIAZEPIN/DIAZEPIN-11-YL)PIPERAZIN-1-YL)-PROPANO IC ACID DERIVATIVES AS H1 AND 5-HT2A-RECEPTOR MODULATORS FOR THE TREATMENT OF SLEEP DISORDERS Alairion, Inc. (US) 2022-08-31 EP disclosed
CN-114929688-A 3- (4- (11H-dibenzo [ b, e ] [1,4] azepin-6-yl) piperazin-1-yl) -and 3- (4- (dibenzo [ b, f ] [1,4] oxazepin/thiazepin/diazepin-11-yl) piperazin-1-yl) -propionic acid derivatives as H1 and 5-HT 2A-receptor modulators for the treatment of sleep disorders 阿莱瑞恩公司 2022-08-19 CN disclosed